Page last updated: 2024-09-05

sb 203580 and Renal Insufficiency, Chronic

sb 203580 has been researched along with Renal Insufficiency, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Che, X; Mou, S; Ni, Z; Shao, X; Tian, L; Wang, Q; Xie, Y; Xu, W; Xu, Y; Zhang, M	1

Other Studies

1 other study(ies) available for sb 203580 and Renal Insufficiency, Chronic

Article	Year
Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:2 Topics: Acute Kidney Injury; Adult; Aged; Animals; Case-Control Studies; Cell Line; Disease Models, Animal; Female; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Humans; Imidazoles; Interleukin-6; Macrophage Activation; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Pyridines; RAW 264.7 Cells; Recombinant Proteins; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha	2017

Article

Year

Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:2

Topics: Acute Kidney Injury; Adult; Aged; Animals; Case-Control Studies; Cell Line; Disease Models, Animal; Female; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Humans; Imidazoles; Interleukin-6; Macrophage Activation; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Pyridines; RAW 264.7 Cells; Recombinant Proteins; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha

2017